A pattern Dobbs created

In the first months after the 2022 Dobbs ruling, abortion access in the United States fragmented into a patchwork. Some states banned abortion outright. Some imposed gestational limits well before fetal viability. Some codified prior Roe-era access. Others fell into legal limbo while pre-Roe statutes returned to force.

A predictable consequence emerged: substantial cross-state travel for abortion. Patients in restrictive states began traveling to less-restrictive neighbors. Clinics in Illinois, Kansas (in some periods), New Mexico, Colorado, and several other states absorbed flows from neighboring restrictive states. The volume of travel-for-care has been substantial — estimates suggest tens of thousands of patients per year now cross state lines for abortion, with the destination concentration depending on which states have most restricted access.

The travel pattern has produced its own set of legal and political fights.

The travel question

The constitutional question of whether states can restrict their residents’ interstate travel for medical care has been theoretically settled since the late 19th century — interstate travel is generally protected under the Privileges and Immunities Clause and the Dormant Commerce Clause. But the specific application to abortion travel post-Dobbs is being tested in real time.

Several restrictive states have considered, and some have enacted, frameworks that target abortion-related travel indirectly:

Aiding-and-abetting statutes. Texas’s SB 8 (the “Heartbeat Act”) created civil liability for anyone who aids or abets an abortion, with civil enforcement by private parties. The “aids or abets” language has been read to potentially cover people who help patients travel — friends who drive them, family who provide funds, providers in destination states.

Provider-targeting statutes. Some restrictive states have considered statutes targeting providers in non-restrictive states who provide abortions to residents of restrictive states. The legal viability of such statutes is contested — they raise extraterritorial jurisdiction issues that federal courts are likely to address.

Conspiracy and material-support frameworks. Some prosecutors in restrictive states have explored treating abortion-related travel under conspiracy or material-support frameworks. This has not yet produced sustained prosecutions, but the legal exposure remains.

The federal protection of interstate travel runs through Supreme Court precedent including Bigelow v. Virginia (1975), Saenz v. Roe (1999), and the broader interstate-travel doctrine. Justice Kavanaugh’s Dobbs concurrence explicitly noted that interstate travel for abortion was constitutionally protected. The legal architecture for prosecuting interstate-travel-related abortion conduct is therefore weak — but the chilling effect of even unsuccessful prosecutions on patients, providers, and supporters is substantial.

Shield laws

State-level shield laws provide a structural response. Enacted in California, New York, Massachusetts, Connecticut, Illinois, Colorado, and others since 2022, shield laws share a common architecture:

Provider protection. Shield laws prohibit state cooperation with out-of-state legal action against providers performing abortion or other reproductive care lawfully under shield-state law. License boards, courts, and law enforcement in the shield state are barred from assisting in prosecutions, civil judgments, or disciplinary proceedings from restrictive states.

Patient protection. Patient information is protected from out-of-state subpoena and legal process. Insurance, pharmacy, and medical records cannot be released without specific shield-state procedural compliance.

Telehealth coverage. Many shield laws explicitly cover providers who prescribe medication abortion via telehealth to patients located in restrictive states — a substantial expansion of access that depends on the legal protection.

Civil action. Some shield laws create civil causes of action allowing providers to sue restrictive-state actors who attempt to enforce restrictive-state laws against shield-state activities.

The shield-law framework is an aggressive constitutional gambit. It rests on the legal premise that one state cannot effectively project its substantive criminal law into another state’s legal system without the other state’s cooperation. Federal courts will, in time, address the validity of specific shield-law provisions; outcomes will shape the architecture of the next decade of post-Dobbs reproductive policy.

The medication-abortion overlay

Medication abortion (the mifepristone-misoprostol regimen) has shifted the geometry. The 2024 Supreme Court ruling in FDA v. Alliance for Hippocratic Medicine left FDA approval of mifepristone intact on standing grounds — but did not foreclose future challenges. Telehealth prescription of medication abortion has expanded, with shield-law-protected providers in non-restrictive states prescribing to patients in restrictive states via mail order.

The pattern is significant. Medication abortion now accounts for the majority of US abortions. The combination of telehealth prescription, mail-order pharmacy, and shield-law protection makes restrictive-state enforcement difficult in practice. Several restrictive states have responded with proposals to restrict mail-order medication abortion specifically; the federal-state conflict is escalating.

The 1873 Comstock Act looms over this landscape. Some legal scholars have argued that the Act, which criminalizes interstate transmission of “obscene” materials including abortion-related items, could be revived to restrict mailing abortion medication. The Department of Justice has, since 2022, taken the position that Comstock does not apply to lawful medication-abortion shipping. A future administration could reverse that position. Federal-court adjudication of Comstock’s modern application is likely.

Digital privacy

A parallel set of fights involves digital privacy. Period-tracking apps, location data from phones, internet search histories, and credit card records all become potential evidence in abortion-related state prosecutions. Several developments:

HHS rulemaking. The 2024 HIPAA Privacy Rule modifications strengthened protection for reproductive healthcare information against out-of-state law enforcement requests.

FTC enforcement. The FTC has brought enforcement actions against data brokers that sold geolocation data including visits to reproductive health clinics.

State-level laws. California’s Delete Act and several state-level data-broker laws have addressed adjacent issues.

Apps and platforms. Period-tracking apps and some other services have moved sensitive data off-device or implemented end-to-end encryption to reduce subpoena exposure.

The digital-privacy fight intersects the broader privacy-law fight covered in the Tech, AI & Data Rights cluster — and is one of the most concrete near-term applications of comprehensive federal privacy legislation, were it to pass.

What to watch

• Federal-court rulings on shield-law constitutionality. First major federal-court tests of shield-law provisions are advancing.
• Restrictive-state prosecutions. Whether sustained prosecutions of cross-state travel actors emerge, and how federal courts address them.
• Comstock interpretation. Federal-court rulings on the modern application of the 1873 Act.
• Mifepristone access. Subsequent challenges to FDA approval; state-level restrictions on mail-order delivery.
• HHS HIPAA enforcement of the 2024 rule modifications.
• State ballot measures. Continuing pattern of pro-access ballot results in red and purple states.
• Federal Women’s Health Protection Act and Right to Contraception Act. Codification proposals.

Bottom line

The post-Dobbs landscape is not stable. Cross-state travel, medication abortion, telehealth prescription, shield laws, and digital privacy infrastructure interact in ways that produce a different access landscape from the one Dobbs explicitly addressed. The constitutional architecture supporting interstate access is robust in principle and is being tested in detail. Defending shield laws, extending state-level access where ballot measures allow, and pursuing federal codification of pre-Dobbs protections are the active policy fronts.